InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.80
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.36
(
-0.14%
)
Bitcoin
63,397.68
(
0.37%
)
Post# of 83
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

busker

Send PM Follow Ignore
Followers 0
Posts 29
Boards Moderated 0
Alias Born 09/27/2006

busker

Re: None

Friday, 12/14/2007 7:24:09 AM

Friday, December 14, 2007 7:24:09 AM

Post# of 83
Phase III Study of PI-88 in Post-Resection Hepatocellular Carcinoma (PATHWAY)

Full study details from FDA
http://clinicaltrials.gov/ct2/show/NCT00568308?term=liver+pi-88&rank=1

busker.the.dog@lycos.com

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up